1. Academic Validation
  2. Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series

Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series

  • Bioorg Med Chem Lett. 2008 Mar 15;18(6):1869-73. doi: 10.1016/j.bmcl.2008.02.015.
Wilna J Moree 1 Ken-ichiro Kataoka Michele M Ramirez-Weinhouse Tatsuki Shiota Minoru Imai Takaharu Tsutsumi Masaki Sudo Noriaki Endo Yumiko Muroga Takahiko Hada Dewey Fanning John Saunders Yoshinori Kato Peter L Myers Christine M Tarby
Affiliations

Affiliation

  • 1 Deltagen Research Laboratories (Former CombiChem, Inc.), 4570 Executive Drive, San Diego, CA 92121, USA. wmoree@neurocrine.com
Abstract

SAR studies were conducted around lead compound 1 using high-throughput parallel solution and solid phase synthesis. Our lead optimization efforts led to the identification of several CCR2b antagonists with potent activity in both binding and functional assays [Compound 71 CCR2b Binding IC(50) 3.2 nM; MCP-1-Induced Chemotaxis IC(50) 0.83 nM; Ca(2+) Flux IC(50) 7.5 nM].

Figures
Products